Effect of combined inhaled corticosteroid-formoterol therapy on short-acting beta2-agonist use in Poland: a retrospective analysis of pharmacy reports
R. Dobek (Warsaw, Poland), W. Barg (Wroclaw, Poland), G. Bochenek (Kraków, Poland), G. Brozek (Katowice, Poland), D. Brzostek (Warsaw, Poland), P. Dabrowiecki (Warsaw, Poland), A. Dabrowski (Warsaw, Poland), R. Gawlik (Katowice, Poland), A. Kucharczyk (Warsaw, Poland), I. Kuprys-Lipinska (Lodz, Poland), A. Mastalerz-Migas (Wroclaw, Poland), E. Zagrajek (Warsaw, Poland), M. Kowalski (Lodz, Poland)
Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma
Session: Clinical and laboratory pharmacology in asthma
Session type: E-poster session
Number: 1411
Disease area: Airway diseases, Paediatric lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Dobek (Warsaw, Poland), W. Barg (Wroclaw, Poland), G. Bochenek (Kraków, Poland), G. Brozek (Katowice, Poland), D. Brzostek (Warsaw, Poland), P. Dabrowiecki (Warsaw, Poland), A. Dabrowski (Warsaw, Poland), R. Gawlik (Katowice, Poland), A. Kucharczyk (Warsaw, Poland), I. Kuprys-Lipinska (Lodz, Poland), A. Mastalerz-Migas (Wroclaw, Poland), E. Zagrajek (Warsaw, Poland), M. Kowalski (Lodz, Poland). Effect of combined inhaled corticosteroid-formoterol therapy on short-acting beta2-agonist use in Poland: a retrospective analysis of pharmacy reports. 1411
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: